A Case of Primary Lung Adenocarcinoma With Recurrent Brain Metastasis due to Transformation to Small Cell Carcinoma During Adjuvant Atezolizumab Therapy

ABSTRACT Histologic transformation from non‐small cell to small cell lung cancer (SCLC) is a resistance mechanism to immune checkpoint inhibitors. We report herein a case of lung adenocarcinoma who developed liver and brain metastases during adjuvant atezolizumab therapy. The patient underwent a cra...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nao Kobayashi, Noriaki Sunaga, Masakiyo Yatomi, Ikuo Wakamatsu, Sohei Muto, Hayato Ikota, Rei Yamaguchi, Yoichi Ohtaki, Toshiteru Nagashima, Nobuteru Kubo, Tomomi Masuda, Yosuke Miura, Hiroaki Tsurumaki, Reiko Sakurai, Yasuhiko Koga, Takeshi Hisada, Toshitaka Maeno
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	Thoracic Cancer
Subjects:	adenocarcinoma immune checkpoint inhibitor non‐small cell lung cancer small cell lung cancer therapeutic resistance
Online Access:	https://doi.org/10.1111/1759-7714.15512
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

A Case of Primary Lung Adenocarcinoma With Recurrent Brain Metastasis due to Transformation to Small Cell Carcinoma During Adjuvant Atezolizumab Therapy

Similar Items